Clinical Trial Update: Study To Evaluate The Effect Of Two Steady State Doses of PF 06882961 On Rosuvastatin And Midazolam Pharmacokinetics In Otherwise Healthy Adult Participants With Obesity [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating steady-state dosing of PF 06882961 on pharmacokinetics of rosuvastatin and midazolam in adults with obesity; study completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Midazolam (Midazolam)
• PF-06882961
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Pfizer | Conditions: Obesity | Phase 1 | Status: COMPLETED | Results posted: 2023-12-01